Cigarette smoke inhibits LPS-induced FABP5 expression by preventing c-Jun binding to the FABP5 promoter.

Cigarette smoking is the primary cause of chronic obstructive pulmonary disease (COPD) with repeated and sustained infections linked to disease pathogenesis and exacerbations. The airway epithelium constitutes the first line of host defense against infection and is known to be impaired in COPD. We h...

Full description

Bibliographic Details
Main Authors: Deviyani Rao, Anne-Laure Perraud, Carsten Schmitz, Fabienne Gally
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2017-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC5436865?pdf=render
_version_ 1819042116836261888
author Deviyani Rao
Anne-Laure Perraud
Carsten Schmitz
Fabienne Gally
author_facet Deviyani Rao
Anne-Laure Perraud
Carsten Schmitz
Fabienne Gally
author_sort Deviyani Rao
collection DOAJ
description Cigarette smoking is the primary cause of chronic obstructive pulmonary disease (COPD) with repeated and sustained infections linked to disease pathogenesis and exacerbations. The airway epithelium constitutes the first line of host defense against infection and is known to be impaired in COPD. We have previously identified Fatty Acid Binding Protein 5 (FABP5) as an important anti-inflammatory player during respiratory infections and showed that overexpression of FABP5 in primary airway epithelial cells protects against bacterial infection and inflammation. While cigarette smoke down regulates FABP5 expression, its mechanism remains unknown. In this report, we have identified three putative c-Jun binding sites on the FABP5 promoter and show that cigarette smoke inhibits the binding of c-Jun to its consensus sequence and prevents LPS-induced FABP5 expression. Using chromatin immunoprecipitation, we have determined that c-Jun binds the FABP5 promoter when stimulated with LPS but the presence of cigarette smoke greatly reduces this binding. Furthermore, cigarette smoke or a mutation in the c-Jun binding site inhibits LPS-induced FABP5 promoter activity. These data demonstrate that cigarette smoke interferes with FABP5 expression in response to bacterial infection. Thus, functional activation of FABP5 may be a new therapeutic strategy when treating COPD patients suffering from exacerbations.
first_indexed 2024-12-21T09:35:47Z
format Article
id doaj.art-49c0262af65646719ddbe685492b1ce3
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-21T09:35:47Z
publishDate 2017-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-49c0262af65646719ddbe685492b1ce32022-12-21T19:08:38ZengPublic Library of Science (PLoS)PLoS ONE1932-62032017-01-01125e017802110.1371/journal.pone.0178021Cigarette smoke inhibits LPS-induced FABP5 expression by preventing c-Jun binding to the FABP5 promoter.Deviyani RaoAnne-Laure PerraudCarsten SchmitzFabienne GallyCigarette smoking is the primary cause of chronic obstructive pulmonary disease (COPD) with repeated and sustained infections linked to disease pathogenesis and exacerbations. The airway epithelium constitutes the first line of host defense against infection and is known to be impaired in COPD. We have previously identified Fatty Acid Binding Protein 5 (FABP5) as an important anti-inflammatory player during respiratory infections and showed that overexpression of FABP5 in primary airway epithelial cells protects against bacterial infection and inflammation. While cigarette smoke down regulates FABP5 expression, its mechanism remains unknown. In this report, we have identified three putative c-Jun binding sites on the FABP5 promoter and show that cigarette smoke inhibits the binding of c-Jun to its consensus sequence and prevents LPS-induced FABP5 expression. Using chromatin immunoprecipitation, we have determined that c-Jun binds the FABP5 promoter when stimulated with LPS but the presence of cigarette smoke greatly reduces this binding. Furthermore, cigarette smoke or a mutation in the c-Jun binding site inhibits LPS-induced FABP5 promoter activity. These data demonstrate that cigarette smoke interferes with FABP5 expression in response to bacterial infection. Thus, functional activation of FABP5 may be a new therapeutic strategy when treating COPD patients suffering from exacerbations.http://europepmc.org/articles/PMC5436865?pdf=render
spellingShingle Deviyani Rao
Anne-Laure Perraud
Carsten Schmitz
Fabienne Gally
Cigarette smoke inhibits LPS-induced FABP5 expression by preventing c-Jun binding to the FABP5 promoter.
PLoS ONE
title Cigarette smoke inhibits LPS-induced FABP5 expression by preventing c-Jun binding to the FABP5 promoter.
title_full Cigarette smoke inhibits LPS-induced FABP5 expression by preventing c-Jun binding to the FABP5 promoter.
title_fullStr Cigarette smoke inhibits LPS-induced FABP5 expression by preventing c-Jun binding to the FABP5 promoter.
title_full_unstemmed Cigarette smoke inhibits LPS-induced FABP5 expression by preventing c-Jun binding to the FABP5 promoter.
title_short Cigarette smoke inhibits LPS-induced FABP5 expression by preventing c-Jun binding to the FABP5 promoter.
title_sort cigarette smoke inhibits lps induced fabp5 expression by preventing c jun binding to the fabp5 promoter
url http://europepmc.org/articles/PMC5436865?pdf=render
work_keys_str_mv AT deviyanirao cigarettesmokeinhibitslpsinducedfabp5expressionbypreventingcjunbindingtothefabp5promoter
AT annelaureperraud cigarettesmokeinhibitslpsinducedfabp5expressionbypreventingcjunbindingtothefabp5promoter
AT carstenschmitz cigarettesmokeinhibitslpsinducedfabp5expressionbypreventingcjunbindingtothefabp5promoter
AT fabiennegally cigarettesmokeinhibitslpsinducedfabp5expressionbypreventingcjunbindingtothefabp5promoter